Posts

Conference: INSIGHT 2021 – an invitation to Berlin. Psychedelic research, therapy and drug development in Berlin

At INSIGHT 2021, scientists and therapists, pharmaceutical industry and anthropology, philosophers, and chemists will come together to determine the potential place of LSD, psilocybin, DMT, MDMA, and other psychedelic substances in the treatment of mental disorders. In addition, we will discuss the use of non-pharmacological methods to alter and cultivate states of consciousness and all that it takes to build such unusual states of consciousness a legitimate and safe place in society.

Writing the histories of psychedelic research: Wirtschaftswoche on German LSD-Researcher Hanscarl Leuner

German journalist Marlene Halser on the LSD-researcher Hanscarl Leuner
“Psychedelic mushrooms are in demand on the stock market – this man paved the way for them” (Wirtschaftswoche)

For almost 30 years, Hanscarl Leuner treated people with LSD and psilocybin at the University Hospital in Göttingen. Substances in which highly valued start-ups are currently investing – while the German researcher has been relegated to the sidelines of society.”
… and a free link to “The History of Psychedelics in Psychiatry”

Video: Psychedelic therapy serious – The physician portal esanum reports about the OVID Clinic Berlin

Pharmacologically based long-term therapies are often the treatment of choice for depression. Augmented psychotherapy, which uses mind-altering substances such as ketamine, is a new approach to helping depressed people. The altered states of consciousness induced in this way are then therapeutically integrated This treatment method, which is still relatively new in Germany, is the focus of Dr. med. Andrea Jungaberle and her colleagues in their clinic in Berlin Friedrichshain. Esanum visited the interdisciplinary team and informed us about the innovative procedure.
The esanum physician network has made a video report about the newly opened OVID Clinic Berlin. In it, Andrea Jungaberle, MD, Sergio Pérez and members of the team of therapists present the concept for psychedelic-augmented psychotherapy. Augmented means “amplified, expanded, intensified”.

Radio: “”High sein” – Henrik Jungaberle on a new edition of the drug education book in Deutschlandfunk Corso

“For anyone who wants to get a differentiated picture”.
Alcohol, coke, pills – the list of available drugs is long, and so is the list of addictions. “Being High” is a handbook that casts a nuanced picture on drugs of all kinds. “We have a very dysfunctional relationship with the people who use them,” author Henrik Jungaberle told Dlf.

Henrik Jungaberle in a Corso conversation with Ulrich Biermann

Podcast: Henrik in conversation with Darek Dwanda on values and programs of the MIND Foundation

Berlin’s MIND Foundation is one of Europe’s largest psychedelic therapy organizations with global aspirations. MIND has a range of amazing programs for therapists, academics, and anyone else interested in new psychedelic therapies. In this episode we discuss a range of issues including European psychedelic landscape, ethics of Psychedelic-Assisted Therapies, cultural issues, issues of growth, and many other issues related to healing with psychedelics.

Gert Scobel discusses drugs as medicine on 3SAT – with Franz Vollenweider, Thomas Metzinger und Magaly Tornay

Gert Scobel discusses new therapies with hallucinogenic drugs with historian Magaly Tornay, psychiatrist Franz Vollenweider, and philosopher and neuroethicist Thomas Metzinger.

Conference: #drugscience2017 – Research, practice, and global change in 21st century drug science

The #drucscience2017-conference presented speakers from medicine, psychotherapy, neurosciences, pharmacology, public health and anthropology to discuss the state of the art in drug science.